The role of cellular immunity in systemic vasculitis.
作者信息
Mathieson P W, Oliveira D B
出版信息
Clin Exp Immunol. 1995 May;100(2):183-5. doi: 10.1111/j.1365-2249.1995.tb03650.x.
Abstract
摘要
相似文献
1
The role of cellular immunity in systemic vasculitis.细胞免疫在系统性血管炎中的作用。
Clin Exp Immunol. 1995 May;100(2):183-5. doi: 10.1111/j.1365-2249.1995.tb03650.x.
2
Cellular aspects of vasculitis--T cell-mediated aspects.血管炎的细胞层面——T细胞介导的层面。
Springer Semin Immunopathol. 2001;23(3):287-98. doi: 10.1007/s002810100077.
3
Pathogenesis and treatment of ANCA-associated systemic vasculitis.抗中性粒细胞胞浆抗体相关性系统性血管炎的发病机制与治疗
J R Soc Med. 1999 Sep;92(9):456-61. doi: 10.1177/014107689909200906.
4
Disease associations with anti-neutrophil cytoplasmic antibodies.
Adv Exp Med Biol. 1993;336:145-55. doi: 10.1007/978-1-4757-9182-2_25.
5
Spectrum of autoimmune responses in systemic vasculitis.
Ann Ital Med Int. 1992 Oct-Dec;7(4):203-8.
6
Animal models in ANCA-vasculitis.抗中性粒细胞胞浆抗体相关性血管炎的动物模型
Clin Exp Immunol. 1995 Jul;101 Suppl 1(Suppl 1):12-5. doi: 10.1111/j.1365-2249.1995.tb06154.x.
7
Pathogenesis of lupus nephritis and ANCA-associated systemic vasculitis: lessons from experimental models.狼疮性肾炎和抗中性粒细胞胞浆抗体相关性系统性血管炎的发病机制：来自实验模型的经验教训。
Am J Kidney Dis. 1998 May;31(5):I-Iii.
8
[ANCA: vasculitis research on the upswing].[抗中性粒细胞胞浆抗体：血管炎研究呈上升趋势]
Z Rheumatol. 1995 Sep-Oct;54(5):277-8.
9
Leptin and ANCA-associated vasculitis: a healthy link?
Rheumatology (Oxford). 2008 Apr;47(4):387-9. doi: 10.1093/rheumatology/kem389. Epub 2008 Feb 11.
10
[What's new in systemic vasculitis?].
Z Rheumatol. 2002 Oct;61(5):610-2. doi: 10.1007/s00393-002-0441-3.
引用本文的文献
1
Central nervous system vasculitis.中枢神经系统血管炎。
Semin Immunopathol. 2009 Nov;31(4):527-36. doi: 10.1007/s00281-009-0183-2. Epub 2009 Nov 12.
2
What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis.关于抗蛋白酶3抗中性粒细胞胞浆抗体你应该了解的内容。T细胞在系统性血管炎发病机制中作用的证据。
Arthritis Res. 2000;2(4):260-2. doi: 10.1186/ar98. Epub 2000 Jun 12.
3
T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.抗中性粒细胞胞浆自身抗体（ANCA）相关系统性血管炎患者存在针对ANCA抗原的T淋巴细胞反应，且在疾病缓解期持续存在。
Clin Exp Immunol. 1998 Jun;112(3):539-46. doi: 10.1046/j.1365-2249.1998.00615.x.
本文引用的文献
1
The current status of neutrophil cytoplasmic antibodies.中性粒细胞胞浆抗体的现状
Clin Exp Immunol. 1989 Nov;78(2):143-8.
2
Serum markers of T cell activation in relapses of Wegener's granulomatosis.韦格纳肉芽肿复发时T细胞活化的血清标志物
Clin Exp Immunol. 1993 Mar;91(3):415-20. doi: 10.1111/j.1365-2249.1993.tb05918.x.
3
Animal models of systemic vasculitis.系统性血管炎的动物模型
J Autoimmun. 1993 Apr;6(2):251-64. doi: 10.1006/jaut.1993.1022.
4
Nomenclature of systemic vasculitides. Proposal of an international consensus conference.系统性血管炎的命名法。国际共识会议提案。
Arthritis Rheum. 1994 Feb;37(2):187-92. doi: 10.1002/art.1780370206.
5
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.单克隆抗体疗法使难治性系统性血管炎长期缓解。
Lancet. 1993 Jun 26;341(8861):1620-2. doi: 10.1016/0140-6736(93)90759-a.
6
T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).韦格纳肉芽肿病（WG）患者中T细胞对蛋白酶3和髓过氧化物酶的反应性。
Clin Exp Immunol. 1994 Dec;98(3):448-53. doi: 10.1111/j.1365-2249.1994.tb05511.x.
7
Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?慢性B19细小病毒感染与系统性坏死性血管炎：机会性感染还是病原体？
Lancet. 1994 May 21;343(8908):1255-8. doi: 10.1016/s0140-6736(94)92152-0.
8
Multiple significance tests: the Bonferroni method.多重显著性检验：邦费罗尼方法
BMJ. 1995 Jan 21;310(6973):170. doi: 10.1136/bmj.310.6973.170.
9
Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG).韦格纳肉芽肿（WG）患者的细胞介导自身免疫。
Clin Exp Immunol. 1995 May;100(2):186-93. doi: 10.1111/j.1365-2249.1995.tb03651.x.
10
Distribution of MHC class II alleles in primary systemic vasculitis.
Kidney Int. 1995 Jan;47(1):294-8. doi: 10.1038/ki.1995.37.
Zotero 插件